Herd Immunity — Thresholds, Myths & Real-World Applications
Herd immunity is the indirect protection from infectious disease that occurs when a large proportion of a population becomes immune, reducing the likelihood that susceptible individuals will contact an infected person. Understanding the threshold and limitations of herd immunity is critical for every doctor who vaccinates, treats infectious disease, or counsels patients about immunisation.
Herd immunity (also called community immunity, population immunity, or social immunity) is the protection of susceptible individuals in a population that arises when a sufficient proportion of the population is immune. The 'herd' effect occurs because immune individuals act as buffers — they break the chain of transmission by failing to propagate the pathogen. Herd immunity is what protects people who cannot be vaccinated (newborns, immunocompromised, vaccine contraindications) and is the ethical core of universal immunisation programmes.
The herd immunity threshold (HIT) is the proportion of the population that must be immune to prevent sustained transmission. It depends on the basic reproduction number (R0) of the pathogen:
HIT = 1 - (1 / R0)
| Disease | R0 | HIT |
|---|---|---|
| Measles | 12-18 | 92-94% |
| Pertussis | 12-17 | 92-94% |
| COVID-19 (Delta) | 5-8 | 80-88% |
| COVID-19 (Omicron) | 8-10 | 88-90% |
| Smallpox | 5-7 | 80-86% |
| SARS | 2-4 | 50-75% |
| Seasonal influenza | 1.3-1.8 | 23-44% |
| Polio | 5-7 | 80-86% |
| Mumps | 4-7 | 75-86% |
| Rubella | 5-7 | 80-86% |
The higher the R0, the higher the proportion that must be immune. Measles, with R0 ~15, requires 93% immune — which is why even small drops in measles vaccination coverage trigger outbreaks.
- Vaccination: The preferred, ethical, and controllable path. Vaccines induce immunity without causing disease, with predictable safety profiles. Vaccine-derived herd immunity has eradicated smallpox, eliminated polio from most countries, and drastically reduced measles, rubella, diphtheria, and Hib globally.
- Natural infection: Arises when a large proportion of the population gets infected, recovers, and develops immunity. This was the strategy proposed by some for COVID-19 ('let it rip'). It is ethically unacceptable for diseases with high mortality, long-term complications, or unknown immunology — and even when acceptable, it is unpredictable in timing, scale, and outcome.
The two paths are not equivalent: natural infection causes deaths and disability that vaccination avoids. For COVID-19, achieving natural herd immunity in India would have meant 20+ lakh additional deaths (estimated based on 0.3% infection fatality rate × 70% of 140 crore population).
- Myth: Once 70% are vaccinated, the disease disappears. Reality: Threshold depends on R0 — for measles it's 93%, for COVID-19 Omicron it's 88-90%. Below threshold, transmission continues at a slower rate.
- Myth: Natural infection is better than vaccination. Reality: Vaccination provides comparable immunity without the risks of severe disease, death, long COVID, or transmission to vulnerable contacts.
- Myth: Herd immunity is permanent. Reality: Immunity wanes (especially for COVID-19). New variants may escape existing immunity. Thresholds must be re-achieved with boosters.
- Myth: Vaccinated individuals don't need to worry about spread. Reality: Some vaccines (e.g., IPV for polio) prevent disease but not carriage — so transmission continues silently. OPV provides herd immunity; IPV does not.
- Myth: Herd immunity protects everyone. Reality: Individuals with primary vaccine failure (no seroconversion), waning immunity, or immunodeficiency remain susceptible despite population-level herd immunity.
COVID-19 challenged classical herd immunity theory in several ways:
- Variant escape: Omicron infected many who were vaccinated or previously infected — herd immunity to one variant did not prevent infection from another.
- Waning immunity: Vaccine-induced immunity against infection wanes after 4-6 months, though protection against severe disease remains robust.
- Sterilising immunity elusive: Vaccines prevent severe disease but not all transmission — so the 'buffer' effect is incomplete.
- Asymmetric immunity: Population-level immunity varied by geography, age, occupation — pockets of susceptibility persisted even when national averages exceeded thresholds.
Result: classical herd immunity — elimination through vaccination — is now considered unlikely for COVID-19. The realistic goal shifted to 'protection from severe disease and health system collapse' rather than 'stop all transmission.' This reframing has profound implications for how vaccines are evaluated, communicated, and deployed. Reference: WHO on herd immunity.
Herd immunity is the conceptual foundation of immunisation programmes — but COVID-19 has forced a rethinking of its limits. For UPSC CMS aspirants, the threshold formula, the R0 values for major diseases, and the lessons from COVID-19 are highly testable PSM topics.